Emil Christensen
Aarhus University, DenmarkExtending Liquid Biopsy Analysis to Personalize Bladder Cancer Diagnostics
9 Jun 2017
Droplet Digital PCR can be used to detect genetic mutations in DNA that allow scientists to predict the progression of cancers into invasive disease. Emil Christensen of Aarhus University, Denmark, explains how this technique can be personalized to individual patients in the near future.
LIKE
1
Related Scientists
-
-
Precision Medicine ProteomicsGeoffrey R. Oxnard M.D. Dana-Farber Cancer Institute, Harvard Medical School -
-
Precision MedicineProfessor Ron M.A. Heeren Maastricht MultiModal Molecular Imaging Institute (M4I), Maastricht University, The Netherlands
-
-
-
ProteomicsJennifer Van Eyk, PhD Director, Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences -
-
Precision MedicineProfessor Steve Conlan Reproductive Biology and Gynaecological Oncology, College of Medicine, Swansea University Medical School -
-
Precision MedicineDr. Priya Chockalingam Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics -
Related Content
Proteomics
Precision Medicine